nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Comparison of Clinical Outcomes following on-versus off-CABG Shows Mixed Results
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 12-13 |
artikel |
2 |
ASTRONAUT Study: Aliskiren Does Not Improve Postdischarge Outcomes in Patients Hospitalized for Chronic Heart Failure
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 26-27 |
artikel |
3 |
BNP Screening, Targeted Care Reduce Heart Failure in At-Risk Patients
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 17-18 |
artikel |
4 |
2013 Canadian Hypertension Education Program Recommendations
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 11-11 |
artikel |
5 |
Cangrelor Offers Protective Benefits in PCI Patients
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 16-17 |
artikel |
6 |
Chronic Coronary Artery Disease: Guideline Update
|
Vinall, Maria |
|
2013 |
13 |
2 |
p. 8-10 |
artikel |
7 |
Digoxin Reduces 30-Day Hospital Admission in Older Ambulatory Patients with Heart Failure
|
Buckley, Rita |
|
2013 |
13 |
2 |
p. 22-23 |
artikel |
8 |
Early Fibrinolysis as Effective as Primary PCI When Reperfusion Delay is Long
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 23-24 |
artikel |
9 |
Emerging Pharmacotherapies: The Future of Heart Failure Management
|
Nichols, Emma Hitt |
|
2013 |
13 |
2 |
p. 34-36 |
artikel |
10 |
Eplerenone Post Myocardial Infarction Plus Standard Treatment May Prevent Adverse Cardiovascular Outcomes
|
Buckley, Rita |
|
2013 |
13 |
2 |
p. 20-21 |
artikel |
11 |
First Clinical Evidence Offered That Inhibiting P-Selectin May Limit Myocardial Damage during PCI
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 19-20 |
artikel |
12 |
High-Dose Rosuvastatin Reduces Contrast-Induced Nephropathy
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 14-15 |
artikel |
13 |
HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 13-14 |
artikel |
14 |
MASS COM Trial: Nonemergency PCI Safe without on-Site Surgery Capability
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 25-26 |
artikel |
15 |
New SAPIEN XT System is Noninferior to and Safer Than Old SAPIEN System
|
Vinall, Phil |
|
2013 |
13 |
2 |
p. 24-25 |
artikel |
16 |
Novel Therapeutics May Lower LDL in Familial Hypercholesterolemia
|
Buckley, Rita |
|
2013 |
13 |
2 |
p. 30-31 |
artikel |
17 |
PDE-5 Inhibition Has No Effect on Measures of Heart Failure
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 19-19 |
artikel |
18 |
Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina
|
Hand, Larry |
|
2013 |
13 |
2 |
p. 21-22 |
artikel |
19 |
STEMI Guidelines: What's New?
|
Vinall, Maria |
|
2013 |
13 |
2 |
p. 28-29 |
artikel |
20 |
The Big 5 for the Practicing Cardiologist
|
Nichols, Emma Hitt |
|
2013 |
13 |
2 |
p. 32-33 |
artikel |
21 |
The TACT Trial: Provocative Results for High-Dose Vitamins and Chelation Therapy
|
Buckley, Rita |
|
2013 |
13 |
2 |
p. 16-16 |
artikel |
22 |
When to Consider Rate Control, Rhythm Control, and Catheter Ablation for AF
|
Kuznar, Wayne |
|
2013 |
13 |
2 |
p. 6-7 |
artikel |